The most common type of liver cancer in children, hepatoblastoma, surprisingly appears to contain many immune cells from a type that has long been overlooked. This is according to a study by researchers at the Princess Máxima Center and UMC Utrecht. Th…
Removing lymph nodes during cancer surgery has saved countless lives in many tumor types. Yet recent research is challenging parts of this long-standing practice.
A company called uniQure has announced promising results from a trial of a new gene therapy for Huntington’s disease. The news has spread quickly through families affected by this condition, who have been desperately waiting for a treatment that can st…
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve.
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as lung and prostate cancer. This approach has effectivel…
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body radiation therapy (SBRT) and surgery achieved simil…
Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called “C3G” and prevent the disease progressing.
Babies exposed to dog allergens in the home have a lower risk of developing asthma by the age of five years, according to research presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands. The researchers also studied …
A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse cancer types without harming normal tissue, University of California, Irvine cancer researchers have demonstrated.
